nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A4—Thiotepa—urinary bladder cancer	0.0679	0.164	CbGbCtD
Delavirdine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0544	0.132	CbGbCtD
Delavirdine—CYP3A5—Etoposide—urinary bladder cancer	0.0472	0.114	CbGbCtD
Delavirdine—CYP2C8—Etoposide—urinary bladder cancer	0.0454	0.11	CbGbCtD
Delavirdine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0421	0.102	CbGbCtD
Delavirdine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0379	0.0918	CbGbCtD
Delavirdine—CYP1A2—Etoposide—urinary bladder cancer	0.0351	0.0851	CbGbCtD
Delavirdine—CYP2C9—Cisplatin—urinary bladder cancer	0.0322	0.078	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0197	0.0478	CbGbCtD
Delavirdine—CYP3A4—Etoposide—urinary bladder cancer	0.0184	0.0446	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0125	0.0304	CbGbCtD
Delavirdine—CYP2C19—urine—urinary bladder cancer	0.0031	0.168	CbGeAlD
Delavirdine—CYP1A2—urine—urinary bladder cancer	0.00253	0.137	CbGeAlD
Delavirdine—CYP2C9—urine—urinary bladder cancer	0.0024	0.13	CbGeAlD
Delavirdine—CYP3A4—urine—urinary bladder cancer	0.00183	0.0991	CbGeAlD
Delavirdine—CYP2D6—urine—urinary bladder cancer	0.0018	0.0975	CbGeAlD
Delavirdine—CYP3A5—prostate gland—urinary bladder cancer	0.000877	0.0474	CbGeAlD
Delavirdine—CYP2C8—renal system—urinary bladder cancer	0.000662	0.0358	CbGeAlD
Delavirdine—CYP1A2—renal system—urinary bladder cancer	0.00062	0.0335	CbGeAlD
Delavirdine—CYP3A5—renal system—urinary bladder cancer	0.000598	0.0323	CbGeAlD
Delavirdine—CYP2C19—vagina—urinary bladder cancer	0.000549	0.0297	CbGeAlD
Delavirdine—CYP2C8—female reproductive system—urinary bladder cancer	0.00053	0.0287	CbGeAlD
Delavirdine—CYP2C8—vagina—urinary bladder cancer	0.00048	0.0259	CbGeAlD
Delavirdine—CYP2C9—female reproductive system—urinary bladder cancer	0.000471	0.0255	CbGeAlD
Delavirdine—CYP3A4—renal system—urinary bladder cancer	0.000448	0.0243	CbGeAlD
Delavirdine—CYP2D6—renal system—urinary bladder cancer	0.000441	0.0239	CbGeAlD
Delavirdine—CYP3A5—vagina—urinary bladder cancer	0.000433	0.0234	CbGeAlD
Delavirdine—CYP3A4—female reproductive system—urinary bladder cancer	0.000359	0.0194	CbGeAlD
Delavirdine—CYP2D6—female reproductive system—urinary bladder cancer	0.000353	0.0191	CbGeAlD
Delavirdine—Asthenia—Gemcitabine—urinary bladder cancer	0.000233	0.000551	CcSEcCtD
Delavirdine—Haematuria—Epirubicin—urinary bladder cancer	0.000233	0.00055	CcSEcCtD
Delavirdine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000232	0.000549	CcSEcCtD
Delavirdine—Weight increased—Doxorubicin—urinary bladder cancer	0.000231	0.000545	CcSEcCtD
Delavirdine—Epistaxis—Epirubicin—urinary bladder cancer	0.00023	0.000544	CcSEcCtD
Delavirdine—Pruritus—Gemcitabine—urinary bladder cancer	0.00023	0.000544	CcSEcCtD
Delavirdine—Nausea—Thiotepa—urinary bladder cancer	0.00023	0.000543	CcSEcCtD
Delavirdine—Sinusitis—Epirubicin—urinary bladder cancer	0.000229	0.000541	CcSEcCtD
Delavirdine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000229	0.000541	CcSEcCtD
Delavirdine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000229	0.00054	CcSEcCtD
Delavirdine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000227	0.000537	CcSEcCtD
Delavirdine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000227	0.000537	CcSEcCtD
Delavirdine—Pruritus—Fluorouracil—urinary bladder cancer	0.000226	0.000535	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000224	0.000529	CcSEcCtD
Delavirdine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000223	0.000528	CcSEcCtD
Delavirdine—Bradycardia—Epirubicin—urinary bladder cancer	0.000223	0.000527	CcSEcCtD
Delavirdine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000223	0.000526	CcSEcCtD
Delavirdine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000221	0.000523	CcSEcCtD
Delavirdine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000221	0.000523	CcSEcCtD
Delavirdine—Urticaria—Etoposide—urinary bladder cancer	0.000221	0.000521	CcSEcCtD
Delavirdine—Stomatitis—Doxorubicin—urinary bladder cancer	0.00022	0.00052	CcSEcCtD
Delavirdine—Jaundice—Doxorubicin—urinary bladder cancer	0.00022	0.00052	CcSEcCtD
Delavirdine—Rhinitis—Epirubicin—urinary bladder cancer	0.00022	0.000519	CcSEcCtD
Delavirdine—Abdominal pain—Etoposide—urinary bladder cancer	0.00022	0.000519	CcSEcCtD
Delavirdine—Body temperature increased—Etoposide—urinary bladder cancer	0.00022	0.000519	CcSEcCtD
Delavirdine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00022	0.000519	CcSEcCtD
Delavirdine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00022	0.000519	CcSEcCtD
Delavirdine—Hepatitis—Epirubicin—urinary bladder cancer	0.000219	0.000518	CcSEcCtD
Delavirdine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000219	0.000517	CcSEcCtD
Delavirdine—Tinnitus—Methotrexate—urinary bladder cancer	0.000218	0.000516	CcSEcCtD
Delavirdine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000218	0.000515	CcSEcCtD
Delavirdine—Asthenia—Cisplatin—urinary bladder cancer	0.000218	0.000514	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000218	0.000514	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000216	0.00051	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—urinary bladder cancer	0.000215	0.000509	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000213	0.000503	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000212	0.000501	CcSEcCtD
Delavirdine—Dizziness—Fluorouracil—urinary bladder cancer	0.000212	0.0005	CcSEcCtD
Delavirdine—Chills—Methotrexate—urinary bladder cancer	0.00021	0.000497	CcSEcCtD
Delavirdine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000207	0.00049	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000207	0.00049	CcSEcCtD
Delavirdine—Alopecia—Methotrexate—urinary bladder cancer	0.000207	0.000489	CcSEcCtD
Delavirdine—Vomiting—Gemcitabine—urinary bladder cancer	0.000207	0.000489	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000206	0.000488	CcSEcCtD
Delavirdine—Rash—Gemcitabine—urinary bladder cancer	0.000205	0.000485	CcSEcCtD
Delavirdine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000205	0.000484	CcSEcCtD
Delavirdine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000205	0.000484	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—urinary bladder cancer	0.000204	0.000483	CcSEcCtD
Delavirdine—Erythema—Methotrexate—urinary bladder cancer	0.000204	0.000482	CcSEcCtD
Delavirdine—Malnutrition—Methotrexate—urinary bladder cancer	0.000204	0.000482	CcSEcCtD
Delavirdine—Headache—Gemcitabine—urinary bladder cancer	0.000204	0.000482	CcSEcCtD
Delavirdine—Vomiting—Fluorouracil—urinary bladder cancer	0.000203	0.000481	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000203	0.00048	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000203	0.000479	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000202	0.000477	CcSEcCtD
Delavirdine—Rash—Fluorouracil—urinary bladder cancer	0.000202	0.000477	CcSEcCtD
Delavirdine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000201	0.000476	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000201	0.000476	CcSEcCtD
Delavirdine—Headache—Fluorouracil—urinary bladder cancer	0.0002	0.000473	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.0002	0.000472	CcSEcCtD
Delavirdine—Dysgeusia—Methotrexate—urinary bladder cancer	0.0002	0.000472	CcSEcCtD
Delavirdine—Asthenia—Etoposide—urinary bladder cancer	0.000199	0.000471	CcSEcCtD
Delavirdine—Back pain—Methotrexate—urinary bladder cancer	0.000197	0.000466	CcSEcCtD
Delavirdine—Chills—Epirubicin—urinary bladder cancer	0.000197	0.000465	CcSEcCtD
Delavirdine—Pruritus—Etoposide—urinary bladder cancer	0.000197	0.000464	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—urinary bladder cancer	0.000194	0.000458	CcSEcCtD
Delavirdine—Nausea—Gemcitabine—urinary bladder cancer	0.000193	0.000457	CcSEcCtD
Delavirdine—Vomiting—Cisplatin—urinary bladder cancer	0.000193	0.000456	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—urinary bladder cancer	0.000192	0.000454	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000192	0.000453	CcSEcCtD
Delavirdine—Rash—Cisplatin—urinary bladder cancer	0.000191	0.000452	CcSEcCtD
Delavirdine—Dermatitis—Cisplatin—urinary bladder cancer	0.000191	0.000451	CcSEcCtD
Delavirdine—Erythema—Epirubicin—urinary bladder cancer	0.000191	0.000451	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—urinary bladder cancer	0.000191	0.000451	CcSEcCtD
Delavirdine—Diarrhoea—Etoposide—urinary bladder cancer	0.00019	0.000449	CcSEcCtD
Delavirdine—Nausea—Fluorouracil—urinary bladder cancer	0.00019	0.000449	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000189	0.000447	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000189	0.000447	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—urinary bladder cancer	0.000188	0.000445	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—urinary bladder cancer	0.000188	0.000444	CcSEcCtD
Delavirdine—Tension—Epirubicin—urinary bladder cancer	0.000187	0.000442	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000187	0.000441	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—urinary bladder cancer	0.000185	0.000438	CcSEcCtD
Delavirdine—Back pain—Epirubicin—urinary bladder cancer	0.000185	0.000436	CcSEcCtD
Delavirdine—Malaise—Methotrexate—urinary bladder cancer	0.000184	0.000434	CcSEcCtD
Delavirdine—Dizziness—Etoposide—urinary bladder cancer	0.000184	0.000434	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000183	0.000433	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—urinary bladder cancer	0.000183	0.000433	CcSEcCtD
Delavirdine—Leukopenia—Methotrexate—urinary bladder cancer	0.000183	0.000431	CcSEcCtD
Delavirdine—Chills—Doxorubicin—urinary bladder cancer	0.000182	0.00043	CcSEcCtD
Delavirdine—Nausea—Cisplatin—urinary bladder cancer	0.00018	0.000426	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—urinary bladder cancer	0.00018	0.000425	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—urinary bladder cancer	0.000179	0.000423	CcSEcCtD
Delavirdine—Cough—Methotrexate—urinary bladder cancer	0.000178	0.00042	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000177	0.000418	CcSEcCtD
Delavirdine—Vomiting—Etoposide—urinary bladder cancer	0.000177	0.000417	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—urinary bladder cancer	0.000177	0.000417	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000177	0.000417	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—urinary bladder cancer	0.000176	0.000417	CcSEcCtD
Delavirdine—Agitation—Epirubicin—urinary bladder cancer	0.000175	0.000414	CcSEcCtD
Delavirdine—Rash—Etoposide—urinary bladder cancer	0.000175	0.000414	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—urinary bladder cancer	0.000175	0.000413	CcSEcCtD
Delavirdine—Headache—Etoposide—urinary bladder cancer	0.000174	0.000411	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—urinary bladder cancer	0.000174	0.000411	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—urinary bladder cancer	0.000174	0.00041	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—urinary bladder cancer	0.000174	0.00041	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—urinary bladder cancer	0.000174	0.00041	CcSEcCtD
Delavirdine—Tension—Doxorubicin—urinary bladder cancer	0.000173	0.000409	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000173	0.000408	CcSEcCtD
Delavirdine—Malaise—Epirubicin—urinary bladder cancer	0.000172	0.000407	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—urinary bladder cancer	0.000171	0.000405	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—urinary bladder cancer	0.000171	0.000405	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—urinary bladder cancer	0.000171	0.000405	CcSEcCtD
Delavirdine—Syncope—Epirubicin—urinary bladder cancer	0.000171	0.000404	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—urinary bladder cancer	0.000171	0.000404	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—urinary bladder cancer	0.000171	0.000403	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00017	0.000401	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—urinary bladder cancer	0.000169	0.000398	CcSEcCtD
Delavirdine—Confusional state—Methotrexate—urinary bladder cancer	0.000168	0.000396	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000168	0.000396	CcSEcCtD
Delavirdine—Cough—Epirubicin—urinary bladder cancer	0.000166	0.000393	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000166	0.000393	CcSEcCtD
Delavirdine—Infection—Methotrexate—urinary bladder cancer	0.000165	0.000391	CcSEcCtD
Delavirdine—Nausea—Etoposide—urinary bladder cancer	0.000165	0.00039	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—urinary bladder cancer	0.000165	0.000389	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000164	0.000387	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—urinary bladder cancer	0.000163	0.000386	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000163	0.000385	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—urinary bladder cancer	0.000162	0.000384	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—urinary bladder cancer	0.000162	0.000384	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—urinary bladder cancer	0.000162	0.000384	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—urinary bladder cancer	0.000162	0.000383	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—urinary bladder cancer	0.000162	0.000382	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—urinary bladder cancer	0.000162	0.000382	CcSEcCtD
Delavirdine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000161	0.00038	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—urinary bladder cancer	0.00016	0.000379	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—urinary bladder cancer	0.000159	0.000376	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—urinary bladder cancer	0.000159	0.000375	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—urinary bladder cancer	0.000159	0.000375	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—urinary bladder cancer	0.000159	0.000375	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—urinary bladder cancer	0.000158	0.000374	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000158	0.000373	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—urinary bladder cancer	0.000157	0.000371	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—urinary bladder cancer	0.000156	0.000369	CcSEcCtD
Delavirdine—Oedema—Epirubicin—urinary bladder cancer	0.000156	0.000368	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—urinary bladder cancer	0.000155	0.000367	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000155	0.000367	CcSEcCtD
Delavirdine—Infection—Epirubicin—urinary bladder cancer	0.000155	0.000366	CcSEcCtD
Delavirdine—Cough—Doxorubicin—urinary bladder cancer	0.000154	0.000364	CcSEcCtD
Delavirdine—Shock—Epirubicin—urinary bladder cancer	0.000153	0.000362	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000152	0.00036	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—urinary bladder cancer	0.000152	0.00036	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—urinary bladder cancer	0.000152	0.000359	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000152	0.000358	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—urinary bladder cancer	0.000151	0.000357	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000151	0.000356	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—urinary bladder cancer	0.00015	0.000356	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—urinary bladder cancer	0.00015	0.000355	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—urinary bladder cancer	0.00015	0.000355	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—urinary bladder cancer	0.00015	0.000355	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—urinary bladder cancer	0.00015	0.000354	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000149	0.000353	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—urinary bladder cancer	0.000149	0.000351	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—urinary bladder cancer	0.000148	0.000351	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000148	0.000351	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—urinary bladder cancer	0.000148	0.00035	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000147	0.000347	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000146	0.000346	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—urinary bladder cancer	0.000146	0.000344	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—urinary bladder cancer	0.000145	0.000343	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000145	0.000342	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—urinary bladder cancer	0.000144	0.00034	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000144	0.000339	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—urinary bladder cancer	0.000143	0.000339	CcSEcCtD
Delavirdine—Infection—Doxorubicin—urinary bladder cancer	0.000143	0.000338	CcSEcCtD
Delavirdine—Pain—Methotrexate—urinary bladder cancer	0.000142	0.000336	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000142	0.000335	CcSEcCtD
Delavirdine—Shock—Doxorubicin—urinary bladder cancer	0.000142	0.000335	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000141	0.000333	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—urinary bladder cancer	0.000141	0.000333	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000141	0.000332	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—urinary bladder cancer	0.00014	0.000331	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—urinary bladder cancer	0.00014	0.00033	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000139	0.000329	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000139	0.000328	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—urinary bladder cancer	0.000138	0.000327	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—urinary bladder cancer	0.000137	0.000324	CcSEcCtD
Delavirdine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000137	0.000324	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000137	0.000324	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000136	0.000321	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000135	0.00032	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—urinary bladder cancer	0.000135	0.000318	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000134	0.000318	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—urinary bladder cancer	0.000134	0.000317	CcSEcCtD
Delavirdine—Constipation—Epirubicin—urinary bladder cancer	0.000133	0.000315	CcSEcCtD
Delavirdine—Pain—Epirubicin—urinary bladder cancer	0.000133	0.000315	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—urinary bladder cancer	0.000132	0.000312	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000132	0.000311	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000132	0.000311	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000131	0.00031	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—urinary bladder cancer	0.00013	0.000308	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000129	0.000306	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000128	0.000304	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000128	0.000303	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—urinary bladder cancer	0.000128	0.000303	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000127	0.000301	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000127	0.0003	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000125	0.000296	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000124	0.000294	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—urinary bladder cancer	0.000124	0.000294	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—urinary bladder cancer	0.000124	0.000292	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Delavirdine—Pain—Doxorubicin—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000123	0.000291	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000123	0.00029	CcSEcCtD
Delavirdine—Asthenia—Methotrexate—urinary bladder cancer	0.000119	0.000282	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000119	0.000281	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000118	0.000278	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—urinary bladder cancer	0.000118	0.000278	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000115	0.000271	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—urinary bladder cancer	0.000114	0.00027	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000114	0.000269	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000114	0.000269	CcSEcCtD
Delavirdine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000114	0.000269	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—urinary bladder cancer	0.000112	0.000264	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—urinary bladder cancer	0.00011	0.00026	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—urinary bladder cancer	0.00011	0.00026	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000107	0.000252	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000106	0.000251	CcSEcCtD
Delavirdine—Vomiting—Methotrexate—urinary bladder cancer	0.000106	0.00025	CcSEcCtD
Delavirdine—Rash—Methotrexate—urinary bladder cancer	0.000105	0.000248	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—urinary bladder cancer	0.000105	0.000248	CcSEcCtD
Delavirdine—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000105	0.00072	CbGpPWpGaD
Delavirdine—Headache—Methotrexate—urinary bladder cancer	0.000104	0.000246	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000104	0.000716	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000104	0.000716	CbGpPWpGaD
Delavirdine—Asthenia—Doxorubicin—urinary bladder cancer	0.000103	0.000244	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—urinary bladder cancer	0.000103	0.000243	CcSEcCtD
Delavirdine—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000102	0.000704	CbGpPWpGaD
Delavirdine—Pruritus—Doxorubicin—urinary bladder cancer	0.000102	0.000241	CcSEcCtD
Delavirdine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.0001	0.000691	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	9.98e-05	0.000686	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	9.92e-05	0.000682	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.92e-05	0.000682	CbGpPWpGaD
Delavirdine—Vomiting—Epirubicin—urinary bladder cancer	9.9e-05	0.000234	CcSEcCtD
Delavirdine—Nausea—Methotrexate—urinary bladder cancer	9.88e-05	0.000234	CcSEcCtD
Delavirdine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	9.88e-05	0.000679	CbGpPWpGaD
Delavirdine—Diarrhoea—Doxorubicin—urinary bladder cancer	9.86e-05	0.000233	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.84e-05	0.000677	CbGpPWpGaD
Delavirdine—Rash—Epirubicin—urinary bladder cancer	9.82e-05	0.000232	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—urinary bladder cancer	9.81e-05	0.000232	CcSEcCtD
Delavirdine—Headache—Epirubicin—urinary bladder cancer	9.76e-05	0.00023	CcSEcCtD
Delavirdine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.74e-05	0.00067	CbGpPWpGaD
Delavirdine—Dizziness—Doxorubicin—urinary bladder cancer	9.53e-05	0.000225	CcSEcCtD
Delavirdine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	9.52e-05	0.000655	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	9.52e-05	0.000655	CbGpPWpGaD
Delavirdine—Nausea—Epirubicin—urinary bladder cancer	9.25e-05	0.000219	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—urinary bladder cancer	9.16e-05	0.000216	CcSEcCtD
Delavirdine—Rash—Doxorubicin—urinary bladder cancer	9.08e-05	0.000215	CcSEcCtD
Delavirdine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	9.08e-05	0.000624	CbGpPWpGaD
Delavirdine—Dermatitis—Doxorubicin—urinary bladder cancer	9.08e-05	0.000214	CcSEcCtD
Delavirdine—Headache—Doxorubicin—urinary bladder cancer	9.03e-05	0.000213	CcSEcCtD
Delavirdine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.95e-05	0.000615	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	8.71e-05	0.000599	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	8.7e-05	0.000598	CbGpPWpGaD
Delavirdine—Nausea—Doxorubicin—urinary bladder cancer	8.56e-05	0.000202	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.37e-05	0.000575	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NAT1—urinary bladder cancer	8.25e-05	0.000567	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	8.25e-05	0.000567	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.11e-05	0.000558	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	7.98e-05	0.000549	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	7.84e-05	0.000539	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	7.77e-05	0.000534	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.62e-05	0.000524	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	7.54e-05	0.000519	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.52e-05	0.000517	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	7.41e-05	0.000509	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	7.36e-05	0.000506	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	7.36e-05	0.000506	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.24e-05	0.000498	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	7.22e-05	0.000496	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	7.22e-05	0.000496	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.14e-05	0.000491	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.08e-05	0.000487	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.01e-05	0.000482	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.91e-05	0.000475	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	6.79e-05	0.000467	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	6.77e-05	0.000466	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	6.77e-05	0.000466	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	6.73e-05	0.000463	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.71e-05	0.000462	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.71e-05	0.000462	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.6e-05	0.000454	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	6.41e-05	0.000441	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	6.25e-05	0.00043	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	6.23e-05	0.000428	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.19e-05	0.000426	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.14e-05	0.000422	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	6.06e-05	0.000417	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.05e-05	0.000416	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	5.77e-05	0.000397	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	5.77e-05	0.000397	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	5.77e-05	0.000397	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.74e-05	0.000394	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.74e-05	0.000394	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	5.73e-05	0.000394	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.64e-05	0.000388	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	5.6e-05	0.000385	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	5.58e-05	0.000384	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.58e-05	0.000383	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.53e-05	0.00038	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.27e-05	0.000362	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.25e-05	0.000361	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.22e-05	0.000359	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	5.22e-05	0.000359	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.13e-05	0.000353	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.09e-05	0.00035	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.01e-05	0.000345	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	5e-05	0.000344	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.8e-05	0.00033	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.72e-05	0.000325	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.67e-05	0.000321	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	4.65e-05	0.00032	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	4.52e-05	0.000311	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	4.5e-05	0.00031	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.47e-05	0.000308	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.46e-05	0.000307	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.46e-05	0.000307	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.43e-05	0.000304	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.43e-05	0.000304	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.35e-05	0.000299	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.28e-05	0.000295	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	4.17e-05	0.000287	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	4.17e-05	0.000287	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.1e-05	0.000282	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.08e-05	0.00028	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.07e-05	0.00028	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.05e-05	0.000278	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	4.05e-05	0.000278	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.03e-05	0.000277	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.91e-05	0.000269	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	3.9e-05	0.000268	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	3.88e-05	0.000267	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.71e-05	0.000255	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.68e-05	0.000253	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.65e-05	0.000251	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	3.61e-05	0.000248	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	3.61e-05	0.000248	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	3.61e-05	0.000248	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.59e-05	0.000247	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	3.57e-05	0.000245	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	3.57e-05	0.000245	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.5e-05	0.000241	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.49e-05	0.00024	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.48e-05	0.000239	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.48e-05	0.000239	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.45e-05	0.000237	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.44e-05	0.000237	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	3.41e-05	0.000235	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	3.36e-05	0.000231	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.36e-05	0.000231	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	3.35e-05	0.00023	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.34e-05	0.000229	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.22e-05	0.000222	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.22e-05	0.000222	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.21e-05	0.00022	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.2e-05	0.00022	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.18e-05	0.000218	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	3.15e-05	0.000217	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.14e-05	0.000216	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.13e-05	0.000215	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.08e-05	0.000212	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.97e-05	0.000204	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.97e-05	0.000204	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.94e-05	0.000202	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.94e-05	0.000202	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.92e-05	0.000201	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.91e-05	0.0002	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.88e-05	0.000198	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.85e-05	0.000196	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.83e-05	0.000194	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.81e-05	0.000193	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	2.8e-05	0.000193	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.71e-05	0.000187	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.68e-05	0.000184	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.61e-05	0.000179	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.6e-05	0.000179	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.58e-05	0.000177	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.58e-05	0.000177	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.55e-05	0.000176	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.52e-05	0.000173	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.51e-05	0.000173	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.51e-05	0.000173	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.5e-05	0.000172	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.47e-05	0.00017	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.46e-05	0.000169	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.45e-05	0.000169	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.44e-05	0.000168	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.43e-05	0.000167	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.43e-05	0.000167	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.42e-05	0.000167	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.4e-05	0.000165	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.39e-05	0.000164	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.37e-05	0.000163	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.35e-05	0.000162	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.3e-05	0.000158	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.28e-05	0.000157	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.26e-05	0.000155	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.23e-05	0.000153	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.23e-05	0.000153	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.2e-05	0.000151	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.17e-05	0.000149	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.14e-05	0.000147	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.1e-05	0.000144	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.1e-05	0.000144	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.09e-05	0.000144	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.03e-05	0.000139	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.02e-05	0.000139	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.01e-05	0.000138	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.01e-05	0.000138	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.99e-05	0.000137	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.99e-05	0.000137	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.99e-05	0.000137	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.98e-05	0.000136	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	0.000136	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.97e-05	0.000135	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.94e-05	0.000133	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.94e-05	0.000133	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.91e-05	0.000131	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.91e-05	0.000131	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.88e-05	0.000129	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.87e-05	0.000129	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.85e-05	0.000127	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.85e-05	0.000127	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.84e-05	0.000126	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.83e-05	0.000126	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.83e-05	0.000126	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.82e-05	0.000125	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.82e-05	0.000125	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	0.000122	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.76e-05	0.000121	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.75e-05	0.000121	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	1.75e-05	0.00012	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.00012	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.72e-05	0.000118	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.71e-05	0.000118	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.71e-05	0.000117	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.69e-05	0.000116	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.67e-05	0.000115	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.63e-05	0.000112	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.62e-05	0.000111	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.61e-05	0.00011	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.6e-05	0.00011	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.57e-05	0.000108	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.56e-05	0.000107	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.000107	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.000107	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.54e-05	0.000106	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.49e-05	0.000102	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.46e-05	0.0001	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	9.99e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.43e-05	9.82e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	9.43e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.37e-05	9.43e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.31e-05	9.03e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.3e-05	8.96e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.3e-05	8.95e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.27e-05	8.71e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.26e-05	8.67e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	8.65e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	8.6e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.21e-05	8.33e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.21e-05	8.31e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	8.24e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	8.24e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.15e-05	7.89e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	7.74e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.12e-05	7.72e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.11e-05	7.65e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.1e-05	7.54e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	7.35e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	7.28e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.05e-05	7.19e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.03e-05	7.1e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	7.04e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	9.8e-06	6.73e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—EP300—urinary bladder cancer	9.34e-06	6.42e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.01e-06	6.19e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.93e-06	6.14e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.75e-06	6.02e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.59e-06	5.91e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.59e-06	5.9e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.52e-06	5.86e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.25e-06	5.67e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.63e-06	5.25e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.28e-06	5e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.75e-06	4.64e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.89e-06	4.05e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.62e-06	3.86e-05	CbGpPWpGaD
